Corporate Governance

Mylan N.V. is a publicly traded company on the NASDAQ Global Select Market and incorporated under the laws of the Netherlands, as set forth in its Articles of Association. 

The Chief Executive Officer and other executive officers of Mylan N.V. carry out the day-to-day conduct of Mylan N.V.'s worldwide businesses at the company's principal offices in Canonsburg, Pennsylvania. Duties and standards of conduct for Mylan employees, officers and directors are set forth in the company’s Code of Business Conduct and Ethics, as well as in the Code of Ethics for the Chief Executive Officer, Chief Financial Officer and Corporate Controller. 

Mylan N.V. is managed and controlled under the oversight of the company's board of directors in the United Kingdom, where the board generally meets. The board has established eight committees, each of which operates pursuant to a written charter. Each director is elected annually by the company’s shareholders. Certain of the directors’ duties, rights and responsibilities are detailed in the company’s Articles of Association, Board Rules, and Corporate Governance Principles.

  • Political Contribution & Trade Association Memberships Report

    From time to time Mylan Inc., a U.S. subsidiary of Mylan N.V., and MyPAC support political candidates and organizations of various parties, as well as ballot initiatives and trade associations which support public policies that contribute to pharmaceutical safety and innovation and further Mylan’s mission to provide 7 billion people with access to high quality medicine.

    Mylan Inc. complies with the laws that govern its lobbying efforts and political contributions. All of our employees must also comply with our Political Contributions and Activity Policy, which can be found above.

    Our semiannual Mylan Inc. Political Contribution & Trade Association Memberships Report provides details of MyPAC which is funded by employee contributions; Mylan's political contributions (if applicable) to any political candidate, political organization, or ballot initiative; and the company's memberships in U.S. trade associations to which we contribute $50,000 a year or more and the portion (if applicable) devoted to lobbying activity.

    Further, in accordance with the U.S. Lobbying Disclosure Act, Mylan files a quarterly report of expenses associated with lobbying the federal government. The report can be found on the U.S. Senate Office of Public Records website or the U.S. House of Representatives Office of the Clerk website.

  • U.S. Supplier Diversity

    At Mylan, we appreciate the value, innovation and quality small and diverse businesses bring to the pharmaceutical industry. Small and diverse businesses are invited to register and build a profile in the Mylan Supplier Diversity Registration Portal, describing your product and/or service offerings so we can match your capabilities with our business needs.

    Supplier Diversity Portal

  • California Declaration

    April 20, 2020: Pursuant to Cal. Health and Safety Code §119400 et seq., Mylan Pharmaceuticals Inc., Mylan Institutional Inc., Mylan Institutional LLC and Mylan Specialty L.P., hereby certify that they are in compliance with the provisions of Cal. Health and Safety Code §119402, including the requirement that they have adopted, and are in compliance with, a Comprehensive Compliance Program that they believe to be in accordance with the Office of Inspector General's Compliance Guidance for Pharmaceutical Manufacturers and the Code on Interactions with Health Care Professionals issued by the Pharmaceutical Research and Manufacturers of America (PhRMA) on or about July 1, 2002 and as revised effective January 1, 2009.

    To obtain a copy of Mylan’s Global Compliance Program and declaration, please call toll-free 866.252.4465 or make an electronic request.